r.sobczak
TL2 · Essen
Contributes reviews on supplier material. Based in Essen.
Joined 14 July 2025 · last posted 10d
98 posts, newest first. Showing up to 150.
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #110 · Devices › Syringes & needles · 17 Jul 2026 · 9 likes Coming back to post #108, because the follow-up matters more than the original answer. Dead volume: residual liquid in the hub and needle after withdrawal. Typical…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #86 · Practice › Storage & stability · 11 Jul 2026 · 0 likes Freezing a reconstituted peptide solution is not automatically protective. Freeze-thaw cycling is one of the harsher things you can do to a protein in solution, and a…
-
Prescription requirements and telehealth models — a second dataset Replied, post #86 · Sourcing › Regulatory · 30 Jun 2026 · 6 likes Whatever the answer on Prescription requirements and telehealth models turns out to be, the method for getting there is the same: state the assumption, do the…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #12 · Compounds › Cagrilintide & amylin analogues · 21 Jun 2026 · 0 likes On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and where a solution that looks fine may already have…
-
Official shortage notices and what they authorise Replied, post #119 · Access › Shortages · 21 Jun 2026 · 4 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Naming conventions for research peptides and the confusion they cause Replied, post #18 · Compounds › Other compounds · 20 Jun 2026 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #4 · Evidence › Preprints · 19 Jun 2026 · 3 likes Adding the measurement that the opening post says would settle it. Adding the boring version of community labels, because the interesting version keeps getting posted…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #49 · Analytics › Method validation · 10 Jun 2026 · 10 likes A definition problem is doing most of the work in this Specificity discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is left…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #122 · Practice › Interactions · 9 Jun 2026 · 18 likes Fair, and the limits you put on it are the part I will remember.
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #43 · Sourcing › Red flags · 4 Jun 2026 · 33 likes This settles it for me, at least until somebody posts a reason it should not.
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #42 · Compounds › Semaglutide · 28 May 2026 · 9 likes Worth separating two things that post #38 runs together. Nobody has said the unglamorous part of semaglutide and gastric emptying yet, so: most of the variation is…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #24 · Pharmacology › Formulation chemistry · 19 May 2026 · 12 likes Trying to state the Solubility limits position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes…
-
An 18-month record including the parts that went badly Replied, post #15 · Outcomes › Progress reports · 13 May 2026 · 0 likes Taking post #12 at face value and following it one step further. The question underneath 18-month record is usually "how would I tell?" rather than "what is true?", and…
-
Spreadsheets: an appreciation — what changed since Replied, post #41 · Lounge › Off topic · 13 May 2026 · 17 likes Thank you — that answers what I came here to find out.
-
Shakes versus food: a pragmatic assessment Replied, post #9 · Nutrition & Training › Protein & intake · 11 May 2026 · 0 likes Everything in post #5 holds. The case it does not cover is the one I have. Taking shakes versus food seriously for a moment rather than deflecting: the honest position…
-
Blind submission and why it changes minds — the long version Replied, post #54 · Sourcing › Independent verification · 3 May 2026 · 8 likes Picking up post #53: that is the part I would want checked first. Repeat testing: if you want to verify the same lot a second time, testing with a different service…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #35 · Practice › Interactions · 30 Apr 2026 · 3 likes Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer. Genuinely open…
-
[2026 update] What a purity-only report leaves out Replied, post #100 · Sourcing › Independent verification · 22 Apr 2026 · 29 likes Taking purity-only seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those two…
-
[2026 update] Buffers, pH and why a formulation is a formulation Replied, post #3 · Pharmacology › Formulation chemistry · 17 Apr 2026 · 2 likes The opening post is the version of this I will quote in future. One addition. Buffers and pH: the pH of a solution is buffered to maintain stability. The buffer system…
-
Choosing which test to pay for, given a fixed budget Replied, post #68 · Sourcing › Independent verification · 13 Apr 2026 · 18 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. Not a conclusion. A place to stand while…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #14 · Devices › Syringes & needles · 13 Apr 2026 · 1 like The most useful reply I ever got about 0.3 ml versus 0.5 ml was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #52 · Data & Tools › Calculators · 21 Mar 2026 · 6 likes Adding the boring version of titration planner refuses, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
-
Second pass at: Submitting a sample: the process end to end Replied, post #15 · Sourcing › Independent verification · 21 Mar 2026 · 0 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. Take the reasoning and check the…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #54 · Start Here › Welcome · 16 Mar 2026 · 6 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #16 · Analytics › Impurities & related substances · 14 Mar 2026 · 0 likes Worth separating Residual solvents and scavengers as a question about the compound from Residual solvents and scavengers as a question about the documentation. They get…
-
Clearance pathways and what renal impairment changes Replied, post #10 · Pharmacology › Pharmacokinetics · 10 Mar 2026 · 1 like Confirming post #9 from a second method, which matters more than confirming it from a second person. Before the thread moves on from clearance pathways — what is the…
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #18 · Compounds › Secretagogues & GH axis · 8 Mar 2026 · 20 likes Taking post #15 at face value and following it one step further. Growth hormone secretagogues act on the ghrelin receptor or on the growth hormone releasing hormone…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #47 · Research Methods › Statistics · 7 Mar 2026 · 0 likes Confidence intervals: rather than a single point estimate, a range of plausible values. A narrow interval means precise measurement; a wide interval means measurement…
-
Research-use-only labelling: what it means and what it does not Replied, post #108 · Sourcing › Regulatory · 25 Feb 2026 · 25 likes Building on post #105 rather than restating it. Second-hand on research-use-only labelling, so weight it accordingly — someone whose method I trust told me this and I…
-
Second pass at: Identical chromatograms across two different lots Replied, post #10 · Sourcing › Red flags · 16 Feb 2026 · 0 likes Nothing here should be read as an accusation against a named company, and the guidelines exist so that reports remain reports. The rule of thumb is fine; the edge cases…
-
[2026 update] Regional warehouse stock versus direct despatch Started this topic · Sourcing › Logistics · 13 Feb 2026 · 11 likes Regional warehouse stock versus direct despatch Writing it up because I had to work it out twice and would rather nobody else did. Working notes on Regional warehouse…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #36 · Practice › Storage & stability · 8 Feb 2026 · 0 likes Adding the measurement that post #33 says would settle it. Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion…
-
Dead volume across syringe and needle combinations Replied, post #68 · Devices › Syringes & needles · 8 Feb 2026 · 27 likes Thank you — that answers what I came here to find out.
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #79 · Clinical › Special populations · 25 Jan 2026 · 2 likes Being outside the studied population does not mean a treatment is unsafe. It means the usual evidence is not available and the reasoning has to be explicit.
-
Journal club: PIONEER 6 as a safety trial Replied, post #14 · Evidence › Journal club · 16 Jan 2026 · 3 likes Nobody has said the unglamorous part of PIONEER 6 yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
[2026 update] Publication patterns in the BPC-157 literature, examined Replied, post #4 · Compounds › Repair & healing peptides · 9 Jan 2026 · 9 likes Publication patterns would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
What to include when your question involves a chromatogram Replied, post #11 · Start Here › How to Ask · 31 Dec 2025 · 0 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #32 · Compounds › Retatrutide · 24 Dec 2025 · 30 likes Discontinuation for adverse effects in phase 2 was not negligible at the higher doses. That figure belongs next to the efficacy figure whenever the efficacy figure is…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #9 · Documentation › Wiki requests · 23 Dec 2025 · 1 like Saving this. It is the version I will quote when the question comes round again.
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #35 · Compounds › Other compounds · 15 Dec 2025 · 11 likes Fragment compounds — where the material is part of a larger natural protein — should be identified by sequence rather than by name, because the naming in this space is…
-
Reading an interaction checker output critically Replied, post #43 · Practice › Interactions · 14 Nov 2025 · 0 likes Nothing here is medical advice and an interaction question is one where the cost of a wrong forum answer is genuinely high. Ask the prescriber or the pharmacist. I have…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #94 · Devices › Cold chain · 23 Oct 2025 · 13 likes Worth separating two things that post #92 runs together. Dry ice is rarely used for this material and brings its own transport constraints. Its absence is not a…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #45 · Compounds › Tirzepatide · 21 Oct 2025 · 0 likes That is a fair summary of where the discussion has got to.
-
Pinch or no pinch, and how needle length changes the answer Replied, post #117 · Practice › Administration · 18 Oct 2025 · 14 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
A preprint whose numbers changed substantially at publication Replied, post #54 · Evidence › Preprints · 15 Sep 2025 · 0 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #78 · Data & Tools › Datasets · 9 Sep 2025 · 17 likes Saving this. It is the version I will quote when the question comes round again.
-
Temperature loggers worth the money Replied, post #26 · Devices › Cold chain · 4 Sep 2025 · 6 likes Building on post #23 rather than restating it. Temperature logging: devices that record temperature over time let you confirm cold chain was maintained. Useful if a…
-
Research-use-only labelling: what it means and what it does not Replied, post #29 · Sourcing › Regulatory · 3 Sep 2025 · 27 likes Post #26 is the version of this I will quote in future. One addition. Where a claim about legality is made here, the useful follow-up is which instrument it rests on.…
-
Column chemistry choices for a 40-residue peptide Replied, post #20 · Analytics › HPLC & UHPLC · 24 Aug 2025 · 1 like Source for the column chemistry choices figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is…
-
An emergency department visit, described afterwards Replied, post #55 · Safety › Adverse events · 17 Aug 2025 · 28 likes Gallbladder symptoms during rapid weight loss are described in this class and are also associated with rapid weight loss generally. Both can be true. That is a…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #45 · Compounds › Retatrutide · 12 Aug 2025 · 22 likes Post #44 is the version of this I will quote in future. One addition. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #9 · Data & Tools › Datasets · 11 Aug 2025 · 10 likes Reframing community side-effect dataset slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen",…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #5 · Evidence › Journal club · 8 Aug 2025 · 32 likes Building on post #4 rather than restating it. The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio…
-
How to research a compound with no human data without deceiving yourself Replied, post #72 · Compounds › Other compounds · 2 Aug 2025 · 5 likes The question underneath research a compound is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you…
-
A field-by-field walk through a certificate of analysis Replied, post #64 · Analytics › COA interpretation · 16 Jul 2025 · 4 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #26 · Practice › Reconstitution · 16 Jul 2025 · 5 likes Coming back to post #22, because the follow-up matters more than the original answer. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #158 · Evidence › Journal club · 14 Jul 2025 · 5 likes Building on post #157 rather than restating it. I keep a log for SURMOUNT-1 specifically because my memory of it turned out to be systematically wrong in one direction.…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #46 · Compounds › Cagrilintide & amylin analogues · 10 Jul 2025 · 1 like The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
-
Whether an aggregate is worth publishing at all: a disputed topic Replied, post #21 · Data & Tools › Datasets · 1 Jul 2025 · 19 likes The arithmetic on whether an aggregate is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch…
-
System suitability injections: if they failed, the run did not happen Replied, post #11 · Analytics › HPLC & UHPLC · 1 Jul 2025 · 5 likes Everything in post #9 holds. The case it does not cover is the one I have. Practical note on system suitability injections: write down what you expect before you look.…
-
EU-wide position versus national implementation Replied, post #14 · Regional › European Union · 29 Jun 2025 · 4 likes Nothing to add, except that this is the answer I would give if asked.
-
Comparing my trajectory with the trial curves, carefully Replied, post #13 · Outcomes › Progress reports · 12 Jun 2025 · 21 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #43 · Regional › UK & Ireland · 6 Jun 2025 · 20 likes For anyone finding this later: the short answer on Pharmacy supply is that it depends on one thing, and the rest of the thread is people identifying which thing.
-
Antibiotics and a course of something with delayed emptying Replied, post #37 · Practice › Interactions · 9 May 2025 · 0 likes Antibiotics looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
A supplier that answers analytical questions with restated claims Replied, post #64 · Sourcing › Red flags · 25 Apr 2025 · 17 likes Prices well below the rest of the market are a fact rather than a finding. They are worth noting and they do not establish anything on their own.
-
Adjudicated events and why the definition matters — the long version Replied, post #116 · Evidence › Trials · 24 Apr 2025 · 1 like Post #113 answers the question as asked. The question underneath it is different. Dropout is information: high dropout rates can indicate tolerability problems or lower…
-
Requesting a page: what makes a good request Replied, post #55 · Documentation › Wiki requests · 13 Apr 2025 · 11 likes Where a request is for a translation or a regional version, the maintenance burden doubles and the proposal should say who carries it. Written quickly, so the reasoning…
-
A certificate with no method stated: what can you conclude? Replied, post #41 · Analytics › COA interpretation · 7 Apr 2025 · 7 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
Preservatives: function, testing, and limits Replied, post #28 · Pharmacology › Formulation chemistry · 5 Apr 2025 · 33 likes Post #27 answers the question as asked. The question underneath it is different. Counterpoint on preservatives, offered without confidence: the same observation is…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #53 · Sourcing › Vendor reports · 4 Apr 2025 · 4 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #77 · Compounds › Cagrilintide & amylin analogues · 31 Mar 2025 · 21 likes Thank you for taking the time. That was more work than a reply usually is.
-
A certificate with no method stated: what can you conclude? Replied, post #10 · Analytics › COA interpretation · 30 Mar 2025 · 3 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Maintainer handover: how it works Replied, post #58 · Meta › Wiki maintenance · 17 Mar 2025 · 11 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #4 · Evidence › Journal club · 15 Mar 2025 · 21 likes Summarising the retatrutide phase 2 obesity paper thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #104 · Pharmacology › Receptor biology · 15 Mar 2025 · 0 likes Building on post #101 rather than restating it. Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation.…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #81 · Analytics › COA interpretation · 14 Mar 2025 · 3 likes Post #78 answers the question as asked. The question underneath it is different. An itemised related-substances table with retention times says considerably more about…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #28 · Practice › Interactions · 11 Mar 2025 · 0 likes Where I would push back on the Anaesthesia and elective surgery consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
Assessing a warm arrival: the decision process Replied, post #11 · Sourcing › Logistics · 8 Mar 2025 · 32 likes Post #9 and I disagree about the size of the effect, not about the direction. Adding the boring version of assessing a warm arrival, because the interesting version…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #135 · Sourcing › Regulatory · 5 Mar 2025 · 3 likes Import rules for personal quantities differ from commercial import rules and both differ by country. Establishing your own position is not something a forum can do for…
-
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #7 · marked as the solution · Clinical › Bloodwork · 27 Feb 2025 · 11 likes The reason hba1c lag is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is silent.
-
Validating a method you did not develop — does this still hold? Replied, post #29 · Analytics › Method validation · 21 Feb 2025 · 32 likes Documented validation is what separates a number from an opinion expressed numerically. That is the whole reason to ask for the procedure identifier rather than the…
-
Canadian access and provincial variation Replied, post #47 · Regional › North America · 2 Feb 2025 · 8 likes A definition problem is doing most of the work in this canadian access and provincial variation discussion. Once the term is pinned down I suspect the disagreement…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #96 · Compounds › Semaglutide · 31 Jan 2025 · 1 like Adding a note of thanks rather than an opinion. I did not know most of that.
-
Levothyroxine timing: a real interaction with a simple fix Replied, post #25 · Practice › Interactions · 28 Jan 2025 · 25 likes Absence of an interaction study is not evidence of no interaction. A great many combinations discussed here have simply never been studied, and saying so is more useful…
-
A page that has drifted out of date and needs a maintainer Replied, post #42 · Documentation › Wiki requests · 21 Dec 2024 · 0 likes Correction requests: if you spot an error in a maintained page, note it here with the specific correction. The maintainer will review and update if justified.
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #14 · Evidence › Journal club · 16 Dec 2024 · 0 likes I would be cautious about generalising from the SUSTAIN 6 example above. It is a good example. It is one example.
-
Transit times by route, from a logged dataset — the long version Replied, post #35 · Sourcing › Logistics · 3 Dec 2024 · 0 likes What I can speak to on Transit times is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #12 · Practice › Dosing & titration · 29 Nov 2024 · 10 likes If you are stepping up mainly because the schedule says so rather than because the current dose has stopped doing what you wanted, that is worth noticing before rather…
-
Time to steady state after a dose increase Replied, post #132 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 0 likes Coming back to post #131, because the follow-up matters more than the original answer. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #4 · Practice › Reconstitution · 3 Nov 2024 · 1 like Worked example, since the arithmetic is the whole question. Five milligrams into one millilitre is 5 mg/mL. A 0.25 mg dose is 0.05 mL, which is five units on a U-100…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #18 · Clinical › Comorbidities · 11 Oct 2024 · 1 like Narrowing post #17, because the general version has more than one answer. I have three months of notes on Hypertension improvement and the honest summary is that the…
-
Gallbladder disease risk with rapid weight loss Replied, post #16 · Clinical › Comorbidities · 5 Oct 2024 · 0 likes Post #14 is right about the mechanism and I think understates the practical bit. Worth stating the null on gallbladder disease risk before we explain it: the…
-
Correlation in a self-tracked dataset: what it can support Replied, post #51 · Research Methods › Statistics · 22 Aug 2024 · 0 likes The confident answers on correlation and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #14 · Analytics › Method validation · 11 Aug 2024 · 0 likes Post #12 describes the usual case. This is about the unusual one. Validation is compound-specific and matrix-specific. A method validated for one peptide is a starting…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #15 · Analytics › COA interpretation · 8 Aug 2024 · 2 likes The arithmetic in post #13 is right; the assumption feeding it is the part to check. Practical experience of Purity assay versus content assay, offered as one case with…
-
How this community labels and discusses unrefereed work Replied, post #94 · Evidence › Preprints · 18 Jul 2024 · 18 likes Author track record is a weak signal and it is a signal. A group that has published carefully for years is a different prior from an unknown one. If that is already…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #6 · marked as the solution · Analytics › COA interpretation · 14 Jul 2024 · 7 likes The arithmetic in post #5 is right; the assumption feeding it is the part to check. Worth stating the null on field-by-field walk through a certificate before we…
-
Follow-up: A partial dose because the pen emptied mid-injection Replied, post #3 · Practice › Administration · 25 Jun 2024 · 16 likes This follows the opening post rather than contradicting it. If you have to inject at a different time of day than usual, that is a much smaller perturbation than it…